"synopsis" may belong to another edition of this title.
"About this title" may belong to another edition of this title.
Shipping:
FREE
Within U.S.A.
Book Description Hardcover. Condition: New. Seller Inventory # DADAX152473165X
Book Description Hardcover. Condition: New. 1st Edition. Book. Seller Inventory # ABE-1694131375002
Book Description Condition: New. Buy with confidence! Book is in new, never-used condition. Seller Inventory # bk152473165Xxvz189zvxnew
Book Description Paperback. Condition: NEW. International Edition, Paperback, Brand New, Same author , ISBN and Cover image may differ. Legal to use despite any disclaimer, We ship to PO , APO and FPO adresses in U.S.A .Choose Expedited Shipping for FASTER DELIVERY.Customer Satisfaction Guaranteed. Seller Inventory # US_9781509868087
Book Description Hardcover. Condition: New. Seller Inventory # Shelf100-048
Book Description Hardcover. Condition: New. Dust Jacket Condition: As New. 1st Edition. Seller Inventory # ABE-1670330142245
Book Description Condition: new. Seller Inventory # newMercantile_152473165X
Book Description Hardcover. Condition: new. New Copy. Customer Service Guaranteed. Seller Inventory # think152473165X
Book Description Hardcover. Condition: New. Dust Jacket Condition: As New. " NEW YORK TIMES BEST SELLER · NAMED ONE OF THE BEST BOOKS OF THE YEAR BY: NPR, The New York Times Book Review, Time, Wall Street Journal, Washington Post · The McKinsey Business Book of the Year The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multimillion-dollar biotech startup founded by Elizabeth Holmesnow the subject of the HBO documentary The Inventorby the prize-winning journalist who first broke the story and pursued it to the end. The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion. Bill Gates In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fund raising round that valued the company at more than $9 billion, putting Holmes worth at an estimated $4.7 billion. There was just one problem: The technology didnt work. A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. Review: Best Book of May 2018: In Bad Blood, the Wall Street Journals John Carreyrou takes us through the step-by-step history of Theranos, a Silicon Valley startup that became almost mythical, in no small part due to its young, charismatic founder Elizabeth Holmes. In fact, Theranos was mythical for a different reason, because the technological promise it was founded uponthat vital health information could be gleaned from a small drop of blood using hand held deviceswas a lie. Carreyrou tracks the experiences of former employees to craft the fascinating story of a company run under a strict code of secrecy, a place where leadership was constantly throwing up smoke screens and making promises that it could not keep. Meanwhile, investors kept pouring in money, turning Elizabeth Holmes into a temporary billionaire. As companies like Walgreens and Safeway strike deals with Theranos, and as even the army tries to get in on the Theranos promise (theres a brief cameo by James Mad Dog Mattis), the plot thickens and the proverbial noose grows tighter. Although I knew how the story ended, I found myself reading this book compulsively. Chris Schluep. Seller Inventory # 016956
Book Description Hardcover. Condition: new. Brand New Copy. Seller Inventory # BBB_new152473165X